Skip to content

Analyst Price Targets

3 Stocks For “Explosive Upside Potential” As Focus Locks In On The Biotech Space

“Understandably, investors have taken a more cautious approach when navigating the confused financial environment, but focus is locking in on the biotech sector as it has been able to withstand the COVID-19-induced pressure on the market,” notes the author of today’s article. She proceeds to highlight three “Strong Buy”-rated biotech stocks trading for less than $5 a share that, with…